FDA Drug Recalls

Recalls / Class II

Class IID-023-2014

Product

Morphine Sulfate Injection, USP, (25mg/mL), 250 mg, 10mL Fill, Single dosage Flip top Vial, (C-II), (NDC 0409-1135-02), Rx Only, Manfactured for Hospira, Inc., Lake Forest, IL 60045 USA.

Brand name
Morphine Sulfate
Generic name
Morphine Sulfate
Active ingredient
Morphine Sulfate
Route
Intravenous
NDCs
0409-1134, 0409-1135
Affected lot / code info
Lot #17368EV Exp 08/13

Why it was recalled

Lack of Assurance of Sterility: Confirmed customer report of leakage of vial contents due to the breaking of the vial neck.

Recalling firm

Firm
Hospira, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
600 N Field Dr Bldg J45, N/A, Lake Forest, Illinois 60045

Distribution

Quantity
29,700 vials
Distribution pattern
Nationwide

Timeline

Recall initiated
2013-09-16
FDA classified
2013-12-02
Posted by FDA
2013-12-11
Terminated
2014-10-28
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-023-2014. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.